# Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
Canonical URL: https://biopharmsignal.com/news/DCTH/delcath-systems-announces-publication-of-chopin-clinical-trial-results-in-the-lancet-oncology
Ticker: DCTH
Company: Delcath Systems
Source: Delcath Systems
Published: 2026-03-03 13:00 EST
Original Source URL: https://delcathsystemsinc.gcs-web.com
## Summary

Publication Highlights Promise of Combined Percutaneous Hepatic Perfusion and Immunotherapy in Metastatic Uveal Melanoma QUEENSBURY, N.Y. --(BUSINESS WIRE)--Mar. 3, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment

## Article Body
Publication Highlights Promise of Combined Percutaneous Hepatic Perfusion and Immunotherapy in Metastatic Uveal Melanoma QUEENSBURY, N.Y. --(BUSINESS WIRE)--Mar. 3, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment
## Recent Company News
- 2026-05-26 20:01 EST — [Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-two-asco-2026-investigator-initiated-trials-in-progress-abstracts) — Source: Delcath Systems
- 2026-05-12 12:00 EST — [Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference](https://biopharmsignal.com/news/DCTH/delcath-systems-to-participate-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference) — Source: Delcath Systems
- 2026-05-07 12:00 EST — [Delcath Systems Reports First Quarter 2026 Results and Business Highlights](https://biopharmsignal.com/news/DCTH/delcath-systems-reports-first-quarter-2026-results-and-business-highlights) — Source: Delcath Systems
- 2026-05-07 11:00 EST — [Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-presentation-of-new-data-on-percutaneous-hepatic-perfusion-with-melphalan-in-liver-dominant-metastatic-breast-cancer-at-esmo-breast-cancer-2026) — Source: Delcath Systems
- 2026-04-23 12:30 EST — [Delcath Systems to Host First Quarter 2026 Earnings Call](https://biopharmsignal.com/news/DCTH/delcath-systems-to-host-first-quarter-2026-earnings-call) — Source: Delcath Systems
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)